AHX Stock Overview
A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Apiam Animal Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.38 |
| 52 Week High | AU$0.56 |
| 52 Week Low | AU$0.24 |
| Beta | 0.16 |
| 1 Month Change | -18.48% |
| 3 Month Change | -21.05% |
| 1 Year Change | 44.23% |
| 3 Year Change | -56.40% |
| 5 Year Change | -12.79% |
| Change since IPO | -70.24% |
Recent News & Updates
Recent updates
There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price
Aug 08
Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%
Feb 24These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively
Oct 12Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004
Sep 02Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Feb 28Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being
Nov 18Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012
Sep 15Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Sep 01A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)
Jun 10With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting
Apr 16Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend
Mar 14Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price
Mar 12Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)
Feb 25How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?
Feb 08
Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 18Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?
Dec 28Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price
Dec 11Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?
Nov 24Shareholder Returns
| AHX | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -3.8% | -3.1% | -2.0% |
| 1Y | 44.2% | -6.6% | 7.8% |
Return vs Industry: AHX exceeded the Australian Healthcare industry which returned -6.6% over the past year.
Return vs Market: AHX exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| AHX volatility | |
|---|---|
| AHX Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: AHX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: AHX's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Chris Richards | www.apiam.com.au |
Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia. It operates through three segments: Clinical Vet Services, Feedlots, and Pigs. The company engages in the provision of veterinary wholesale, laboratories, warehousing and logistics, and other ancillary services.
Apiam Animal Health Limited Fundamentals Summary
| AHX fundamental statistics | |
|---|---|
| Market cap | AU$68.45m |
| Earnings (TTM) | AU$4.93m |
| Revenue (TTM) | AU$204.66m |
13.9x
P/E Ratio0.3x
P/S RatioIs AHX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AHX income statement (TTM) | |
|---|---|
| Revenue | AU$204.66m |
| Cost of Revenue | AU$157.49m |
| Gross Profit | AU$47.17m |
| Other Expenses | AU$42.23m |
| Earnings | AU$4.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.027 |
| Gross Margin | 23.05% |
| Net Profit Margin | 2.41% |
| Debt/Equity Ratio | 52.7% |
How did AHX perform over the long term?
See historical performance and comparisonDividends
5.3%
Current Dividend Yield72%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 14:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Apiam Animal Health Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Louis Bannon | CCZ Equities Pty Limited |
| Jonathon Higgins | Shaw and Partners Limited |